A Study Evaluating the Efficacy and Safety of Xywav Expanded Dosing vs Placebo in Participants With Narcolepsy or IH
Clinical trial NCT07625280 · RECRUITING
Trial details
- NCT number
- NCT07625280
- Sponsor
- Jazz Pharmaceuticals
- Status
- RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2026-07-09
- Primary completion
- 2027-12-23
- Enrollment
- 120
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.